Quick Answer
AbCellera Biologics Inc. reported Operating Income of -$217.10 million for fiscal year 2025.
AbCellera Biologics Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$217.10M | +31.0% |
| 2024 | -$314.77M | -32.7% |
| 2023 | -$237.21M | -209.6% |
| 2022 | $216.51M | +5.9% |
| 2021 | $204.41M | +31.0% |
| 2020 | $156.03M | +3889.9% |
| 2019 | -$4.12M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$76.28M | +18.6% | -53.8% |
| June 30, 2025 | -$49.59M | +46.9% | +20.9% |
| March 31, 2025 | -$62.66M | -14.1% | +33.1% |
| September 30, 2024 | -$93.66M | -70.6% | -0.2% |
| June 30, 2024 | -$93.45M | -81.9% | -70.2% |
| March 31, 2024 | -$54.89M | +15.4% | -0.0% |
| September 30, 2023 | -$54.89M | -245.5% | -6.8% |
| June 30, 2023 | -$51.39M | -512.1% | +20.8% |
- AbCellera Biologics Inc. showed an increase of +31.0% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, AbCellera Biologics Inc.’s operating income has declined by 5173.3% (from -$4.12 million to -$217.10 million).
- The most recent figure is from AbCellera Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: